Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Completed · Phase 3 · Has a placebo group
Conditions studied: GVHD, Adult Acute Myeloid Leukemia, Adult Acute Lymphoid Leukemia, Myelodysplastic Syndrome
In brief
The study objective is to compare the efficacy and safety of US-ATG-F as a supplement to standard of care prophylaxis versus standard of care prophylaxis alone in moderate to severe chronic GVHD-free survival.
Key facts
- Study ID
- NCT01295710
- Run by
- Neovii Biotech
- People needed
- 260
- Starts
- 2011-10-10
- Expected to finish
- 2015-10-15
- Last updated by the study team
- 2019-04-09
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- City of Hope — Duarte, California, United States
- Stanford University Medical Center, BMT — Stanford, California, United States
- University of Florida Shands Cancer Center — Gainesville, Florida, United States
- Moffitt Cancer Center — Tampa, Florida, United States
- University of Chicago Medical Center — Chicago, Illinois, United States
- Loyola University Medical Center — Maywood, Illinois, United States
- University of Kansas Medical Center — Westwood, Kansas, United States
- Tulane University Health Sciences Center — New Orleans, Louisiana, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Mayo Clinic — Rochester, Minnesota, United States
- Washington University Medical Center — St Louis, Missouri, United States
- Weill Cornell Medical Center — New York, New York, United States
- University of North Carolina Hospitals — Chapel Hill, North Carolina, United States
- Duke University Medical Center — Durham, North Carolina, United States
- University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States
- Oregon Health and Science University — Portland, Oregon, United States
- Penn State Hershey Cancer Institute — Hershey, Pennsylvania, United States
- Abramson Cancer Center of the University at Perlman Center for Advanced Medicine — Philadelphia, Pennsylvania, United States
- Vanderbilt University Medical Center, Vanderbilt Ingram Cancer Center — Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center — Dallas, Texas, United States
- Texas Transplant Physician's Group — San Antonio, Texas, United States
- University of Utah School of Medicine — Salt Lake City, Utah, United States
- VA Puget Sound Healthcare System — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.